Spyre Therapeutics Inc (FRA:3920)
€ 77 (0%) Market Cap: 6.88 Bil Enterprise Value: 6.36 Bil PE Ratio: 0 PB Ratio: 13.80 GF Score: 33/100

Spyre Therapeutics Inc (FRA:3920) Transcripts

  • 1